NewsRoom Articles - Page 667 of 1422

MondayFeb 17, 2020 1:30 pm

Tower One Wireless Corp. (CSE: TO) (OTC: TOWTF) Starts Presentation at NobleCon16

Tower One Wireless Corp.'s (CSE: TO) (OTC: TOWTF) principal business is to build, own and operate multi-tenant wireless telecommunications infrastructure (“towers”) in Latin America. Tower One leases space on its towers to mobile network operators. The company is focused on the build-to-suit tower industry whereby a long-term lease is secured with a tenant prior to building a tower. The company operates in the three largest Spanish speaking countries in Latin America (Colombia, Mexico and Argentina) with a combined population of approximately 220 million people. For more information, visit the company’s website at https://www.toweronewireless.com/ About NetworkNewsWire NetworkNewsWire (NNW) is a financial…

MondayFeb 17, 2020 1:30 pm

Tribune Publishing Company (NASDAQ: TPCO) Starts Presentation at NobleCon16

Tribune Publishing (NASDAQ: TPCO) is a media company rooted in award-winning journalism. Headquartered in Chicago, Tribune Publishing operates local media businesses including the Chicago Tribune, New York Daily News, The Baltimore Sun, Orlando Sentinel, South Florida's Sun-Sentinel, Virginia's Daily Press and The Virginian-Pilot, The Morning Call of Lehigh Valley, Pennsylvania and the Hartford Courant. In addition to award-winning local media businesses, Tribune Publishing operates national and international brands such as Tribune Content Agency and The Daily Meal and is the majority owner of the product review website BestReviews. Tribune Publishing creates and distributes content across its media portfolio, offering integrated…

MondayFeb 17, 2020 1:30 pm

Genprex Inc. (NASDAQ: GNPX) Starts Presentation at NobleCon16

Genprex (NASDAQ: GNPX) is a clinical-stage gene therapy company developing potentially life-changing technologies for cancer patients based upon a unique proprietary technology platform. The company’s lead product candidate, Oncoprex™ immunogene therapy for non-small cell lung cancer (“NSCLC”), has a multimodal mechanism of action whereby it interrupts cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis, or programmed cell death, in cancer cells, and modulates the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance. For more information, visit the company’s website at www.genprex.com About NetworkNewsWire NetworkNewsWire…

MondayFeb 17, 2020 1:00 pm

SRAX Inc. (NASDAQ: SRAX) Starts Presentation at NobleCon16

SRAX (NASDAQ: SRAX) is a digital marketing and consumer data management technology company. SRAX's technology unlocks data to reveal brands' core consumers and their characteristics across marketing channels. Monetizing its data sets, SRAX is growing multiple recurring revenue streams through its various platforms. Through the BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data thereby offering everyone in the Internet ecosystem choice, transparency and compensation. SRAX's tools deliver a digital competitive advantage for brands in the CPG, investor relations, luxury and lifestyle verticals by integrating all aspects of the advertising experience,…

MondayFeb 17, 2020 1:00 pm

ProMIS Neurosciences Inc. (TSX: PMN) (OTCQB: ARFXF) Starts Presentation at NobleCon16

ProMIS Neurosciences (TSX: PMN) (OTCQB: ARFXF) is a development-stage biotechnology company focused on discovering and developing antibody therapeutics selectively targeting toxic oligomers implicated in the development and progression of neurodegenerative diseases, in particular Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and Parkinson’s disease (PD). The company’s proprietary target discovery platform is based on the use of two complementary thermodynamic, computational discovery engines - ProMIS and Collective Coordinates - to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. For more information, visit the company’s website at https://promisneurosciences.com/ About NetworkNewsWire NetworkNewsWire (NNW) is a financial…

MondayFeb 17, 2020 1:00 pm

Euroseas Ltd. (NASDAQ: ESEA) Starts Presentation at NobleCon16

Euroseas (NASDAQ: ESEA) was formed in May 2005 to consolidate the ship owning interests of the Pittas family of Athens, Greece, which has been in the shipping business over the past 140 years. Euroseas operates in the container shipping market. The company’s operations are managed by Eurobulk Ltd., an ISO 9001:2008 and ISO 14001:2004 certified affiliated ship management company responsible for the day-to-day commercial and technical management and operations of the vessels. Euroseas employs its vessels on spot and period charters and through pool arrangements. The company has a fleet of 19 vessels, including 14 feeder containerships and five intermediate container…

MondayFeb 17, 2020 12:30 pm

EuroDry Ltd. (NASDAQ: EDRY) Starts Presentation at NobleCon16

EuroDry (NASDAQ: EDRY) operates in the dry cargo, drybulk shipping market. Company operations are managed by Eurobulk Ltd., an ISO 9001:2008 and ISO 14001:2004-certified affiliated ship management company and Eurobulk (Far East) Ltd. Inc., which are responsible for the day-to-day commercial and technical management and operations of the vessels. EuroDry employs its vessels on spot and period charters. The company has a fleet of seven vessels, including four Panamax drybulk carriers, one Ultramax drybulk carrier and two Kamsarmax drybulk carriers. EuroDry’s seven drybulk carriers have a total cargo capacity of 528,931 dwt. For more information, visit the company’s website at…

MondayFeb 17, 2020 12:30 pm

Educational Development Corp. (NASDAQ: EDUC) Starts Presentation at NobleCon16

Educational Development (NASDAQ: EDUC) (“EDC”) is a publishing company specializing in books for children. EDC is the exclusive United States trade co-publisher of the line of educational children’s books produced in the United Kingdom by Usborne Publishing Limited, and also exclusively publishes books through its ownership of Kane Miller Book Publisher – both of which are international award-winning publishers of children’s books. EDC’s current catalog contains over 2,000 titles, with new additions semi-annually. Both Usborne and Kane Miller products are sold via 4,000 retail outlets and by independent consultants, who hold book showings in individual homes, through social media, book…

MondayFeb 17, 2020 12:30 pm

International Seaways Inc. (NYSE: INSW) Starts Presentation at NobleCon16

International Seaways (NYSE: INSW) is one of the largest tanker companies worldwide providing energy transportation services for crude oil and petroleum products in International Flag markets. International Seaways owns and operates a fleet of 42 vessels, including 13 VLCCs, two Suezmaxes, six Aframaxes/LR2s, 12 Panamaxes/LR1s and seven MR tankers. Through joint ventures, International Seaways currently has ownership interests in two floating storage and offloading service vessels. The company has an experienced team committed to the highest operating practices and the highest levels of customer service and operational efficiency. For more information, visit the company’s website at www.intlseas.com About NetworkNewsWire NetworkNewsWire…

MondayFeb 17, 2020 12:30 pm

Matinas BioPharma Inc. (NYSE: MTNB) Starts Presentation at NobleCon16

Matinas BioPharma (NYSE: MTNB) is a clinical-stage biopharmaceutical company focused on development of its lead product candidate, MAT9001, for the treatment of cardiovascular and metabolic conditions. MAT9001 is a prescription-only omega-3 fatty acid-based composition, comprised primarily of EPA and DPA, under development for hypertriglyceridemia, that was specifically designed to overcome the shortcomings seen from other agents in the omega-3 class. Matinas BioPharma is also developing MAT2203, an oral, encochleated formulation of amphotericin B, to treat serious invasive fungal infections. The drug is based on the company’s proprietary lipid nano-crystal (LNC) platform technology which can help solve complex challenges relating to…